126 related articles for article (PubMed ID: 35584987)
1. Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5-nitrothiophene derivatives for anticancer activity.
Nuha D; Evren AE; Çiyanci ZŞ; Temel HE; Akalin Çiftçi G; Yurttaş L
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200105. PubMed ID: 35584987
[TBL] [Abstract][Full Text] [Related]
2. New chromanone derivatives containing thiazoles: Synthesis and antitumor activity evaluation on A549 lung cancer cell line.
Yurttaş L; Temel HE; Aksoy MO; Bülbül EF; Çiftçi GA
Drug Dev Res; 2022 Apr; 83(2):470-484. PubMed ID: 34532880
[TBL] [Abstract][Full Text] [Related]
3. A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer.
Orujova T; Ece A; Akalın Çiftçi G; Özdemir A; Altıntop MD
Drug Dev Res; 2023 Apr; 84(2):185-199. PubMed ID: 36469421
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent.
Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P
Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Antiproliferative Potency of Pyrido[2,3-d]Pyrimidine Derivatives: Studies on Design, Synthesis, Anticancer Evaluation, SAR, Docking, and DFT Calculations.
Abd-Alsalam E; Hafez HN; Assay MG; Ali AK; El-Farargy AF; Abbass EM
Chem Biodivers; 2024 Feb; 21(2):e202301682. PubMed ID: 38084395
[TBL] [Abstract][Full Text] [Related]
7. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
8. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents.
Ashmawy FO; Gomha SM; Abdallah MA; Zaki MEA; Al-Hussain SA; El-Desouky MA
Molecules; 2023 May; 28(11):. PubMed ID: 37298747
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
11. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
12. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
13. A New Synthesis of Poly Heterocyclic Compounds Containing [1,2,4]triazolo and [1,2,3,4]tetrazolo Moieties and their DFT Study as Expected Anti-cancer Reagents.
Abdelrehim EM; El-Sayed DS
Curr Org Synth; 2020; 17(3):211-223. PubMed ID: 32101129
[TBL] [Abstract][Full Text] [Related]
14. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
El-Naggar AM; El-Hashash MA; Elkaeed EB
Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
[TBL] [Abstract][Full Text] [Related]
15. Single crystal XRD, DFT investigations and molecular docking study of 2- ((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino)naphthalene-1,4-dione as a potential anti- cancer lead molecule.
P R KR; Mary YS; Fernandez A; S AP; Mary YS; Thomas R
Comput Biol Chem; 2019 Feb; 78():153-164. PubMed ID: 30530296
[TBL] [Abstract][Full Text] [Related]
16. New phosphate derivatives of betulin as anticancer agents: Synthesis, crystal structure, and molecular docking study.
Chrobak E; Kadela-Tomanek M; Bębenek E; Marciniec K; Wietrzyk J; Trynda J; Pawełczak B; Kusz J; Kasperczyk J; Chodurek E; Paduszyński P; Boryczka S
Bioorg Chem; 2019 Jun; 87():613-628. PubMed ID: 30947097
[TBL] [Abstract][Full Text] [Related]
17. Structural elucidation, theoretical investigation, biological screening and molecular docking studies of metal(II) complexes of NN donor ligand derived from 4-(2-aminopyridin-3-methylene)aminobenzoic acid.
Konakanchi R; Pamidimalla GS; Prashanth J; Naveen T; Kotha LR
Biometals; 2021 Jun; 34(3):529-556. PubMed ID: 33651218
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic Effect of Novel Benzimidazole Derivatives Bearing Pyridyl/Pyrimidinyl Piperazine Moiety.
Çiftçi GA; Temel HE; Yurttaş L
Anticancer Agents Med Chem; 2022; 22(9):1780-1792. PubMed ID: 34238172
[TBL] [Abstract][Full Text] [Related]
20. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
